Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| MK0594-003 | |||
| 2005_102 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is designed to investigate whether a new drug may offer safe and effective treatment for patients with overactive bladder.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MK0594 | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Change in baseline in average daily micturitions as recorded on patient voiding diaries. | Change in baseline in average daily micturitions as recorded on patient voiding diaries. | Duration of Trial |
| Measure | Description | Time Frame |
|---|---|---|
| The incidence of dry mouth. | The incidence of dry mouth. | Duration of Treatment |
| Average daily strong urgency, total incontinence, and Urge UI episodes from voiding diaries. | Average daily strong urgency, total incontinence, and Urge UI episodes from voiding diaries. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 20639026 | Derived | Frenkl TL, Zhu H, Reiss T, Seltzer O, Rosenberg E, Green S. A multicenter, double-blind, randomized, placebo controlled trial of a neurokinin-1 receptor antagonist for overactive bladder. J Urol. 2010 Aug;184(2):616-22. doi: 10.1016/j.juro.2010.03.147. Epub 2010 Jun 19. |
Not provided
Not provided
| ID | Term |
|---|---|
| D014549 | Urinary Incontinence |
| D053201 | Urinary Bladder, Overactive |
| ID | Term |
|---|---|
| D014555 | Urination Disorders |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Duration of Treatment |
| Global assessment of improvement in UI, perception of urgency, and bother of UI symptoms. | Global assessment of improvement in UI, perception of urgency, and bother of UI | Duration of Treatment |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D059411 | Lower Urinary Tract Symptoms |
| D020924 | Urological Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001745 | Urinary Bladder Diseases |